XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Total 
stockholders’
equity attributable to T. Rowe Price Group, Inc.
Common stock
Additional capital in excess of par value
Retained earnings
AOCI
[1]
Non-controlling interests in consolidated entities
Beginning balance (in shares) at Dec. 31, 2023     223,938,000        
Balances at beginning of period at Dec. 31, 2023 $ 9,697.1 $ 9,505.1 $ 44.8 $ 431.7 $ 9,076.1 $ (47.5) $ 192.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 587.0 573.8     573.8   13.2
Other comprehensive income (loss), net of tax (2.1) (2.1)       (2.1)  
Dividends declared (285.0) (285.0)     (285.0)    
Common stock-based compensation plans activity:              
Shares issued upon option exercises (in shares)     246,000        
Shares issued upon option exercises 15.4 15.4   15.4      
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (in shares)     27,000        
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (1.4) (1.4)   (1.4)      
Stock-based compensation expense 58.4 58.4   58.4      
Restricted stock units issued as dividend equivalents 0.0     0.1 (0.1)    
Common shares repurchased (in shares)     (717,000)        
Common shares repurchased (80.1) (80.1) $ (0.1) (80.0)      
Net contributions to non-controlling interests in consolidated entities 0.2           0.2
Ending balance (in shares) at Mar. 31, 2024     223,494,000        
Balances at end of period at Mar. 31, 2024 9,989.5 9,784.1 $ 44.7 424.2 9,364.8 (49.6) 205.4
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2023 594.1            
Increase (Decrease) in Temporary Equity [Roll Forward]              
Net income (loss) 19.6            
Other comprehensive income (loss), net of tax (1.6)            
Net subscriptions into T. Rowe Price investment products 92.7            
Net deconsolidations of T. Rowe Price investment products (28.1)            
Ending balances attributable to redeemable non-controlling interests at Mar. 31, 2024 676.7            
Beginning balance (in shares) at Dec. 31, 2024     222,966,000        
Balances at beginning of period at Dec. 31, 2024 10,506.1 10,345.4 $ 44.6 311.9 10,040.6 (51.7) 160.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 490.1 490.5     490.5   (0.4)
Other comprehensive income (loss), net of tax (0.2) (0.2)       (0.2)  
Dividends declared $ (288.8) (288.8)     (288.8)    
Common stock-based compensation plans activity:              
Shares issued upon option exercises (in shares) 314,509   231,000        
Shares issued upon option exercises $ 15.2 15.2   15.2      
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (in shares)     5,000        
Shares issued upon vesting of restricted stock units, net of shares withheld for taxes (0.2) (0.2)   (0.2)      
Stock-based compensation expense 50.3 50.3   50.3      
Restricted stock units issued as dividend equivalents 0.0     0.1 (0.1)    
Common shares repurchased (in shares)     (2,141,000)        
Common shares repurchased (217.5) (217.5) $ (0.4) (217.1)      
Net contributions to non-controlling interests in consolidated entities 0.1           0.1
Ending balance (in shares) at Mar. 31, 2025     221,061,000        
Balances at end of period at Mar. 31, 2025 10,555.1 $ 10,394.7 $ 44.2 $ 160.2 $ 10,242.2 $ (51.9) $ 160.4
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2024 944.0            
Increase (Decrease) in Temporary Equity [Roll Forward]              
Net income (loss) 14.6            
Other comprehensive income (loss), net of tax 3.1            
Net subscriptions into T. Rowe Price investment products 90.6            
Net deconsolidations of T. Rowe Price investment products (75.1)            
Ending balances attributable to redeemable non-controlling interests at Mar. 31, 2025 $ 977.2            
[1] Accumulated other comprehensive income